Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons

Brain Research

Volumn 819, Issue 1-2, 1999, Pages 170-173

  Shinpo, Kazuyoshi ^a   Kikuchi, Seiji ^a   Moriwaka, Fumio ^a   Tashiro, Kunio ^a  

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Ceramide; Mesencephalic neuron; Neuroprotection; Parkinson's disease; SPP; TNF

Indexed keywords

CERAMIDE; EXCITOTOXIN; GLUTAMIC ACID; N,N DIMETHYLSPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG METABOLISM; EMBRYO; MESENCEPHALON; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CERAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; ENZYME INHIBITORS; GLUTAMIC ACID; LYSOPHOSPHOLIPIDS; MESENCEPHALON; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPHINGOSINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033585874     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01354-7     Document Type: Article

References (21)

1. Barger S.W., Mattson M.P. Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res. Mol. Brain Res. 40:1996;116-126.
2. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:1996;782-784. [see comments].
3. Boka G., Anglade P., Wallach D., Javoy A.F., Agid Y., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172:1994;151-154.
4. Brugg B., Michel P.P., Agid Y., Ruberg M. Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66:1996;733-739.
5. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
6. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S., Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381:1996;800-803.
7. Edsall L.C., Pirianov G.G., Spiegel S. Involvement of sphingosine-1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 17:1997;6952-6960.
8. France L.V., Brugg B., Michel P.P., Agid Y., Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J. Neurochem. 69:1997;1612-1621.
9. Goodman Y., Mattson M.P. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J. Neurochem. 66:1996;869-872.
10. Houzen H., Kikuchi S., Kanno M., Shinpo K., Tashiro K. Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons. J. Neurosci. Res. 50:1997;990-999.
11. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson's disease. Proc. Natl. Acad. Sci. USA. 94:1997;7531-7536.
12. Kikuchi S., Kim S.U. Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture. J. Neurosci. Res. 36:1993;558-569.
13. Lipton S.A. Janus faces of NF-kappaB: neurodestruction versus neuroprotection. Nat. Med. 3:1997;20-22. [news].
14. Mattson M.P., Goodman Y., Luo H., Fu W., Furukawa K. Activation of NF-kappa B protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:1997;681-697.
15. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T. Tumor necrosis factor-alpha (TNF-αlpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165:1994;208-210.
16. Paquet M., Tremblay M., Soghomonian J.J., Smith Y. AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J. Neurosci. 17:1997;1377-1396.
17. Prehn J.H. Marked diversity in the action of growth factors on N-methyl-D-aspartate-induced neuronal degeneration. Eur. J. Pharmacol. 306:1996;81-88.
18. Rothwell N.J., Luheshi G.N. Brain TNF: damage limitation or damaged reputation? Nat. Med. 2:1996;746-747.
19. Taglialatela G., Robinson R., Perez P.J. Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J. Neurosci. Res. 47:1997;155-162.
20. Wang C.Y., Mayo M.W., Baldwin A.J. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 274:1996;784-787. [see comments].
21. Yatomi Y., Ruan F., Megidish T., Toyokuni T., Hakomori S., Igarashi Y. N,N-Dimethylsphingosine inhibition of sphingosine kinase and sphingosine-1-phosphate activity in human platelets. Biochemistry. 35:1996;626-633.